Epstein Secrets

. Epstein's foundation, which is now defunct, also gave $100,000 to pay the salary of Ben Goertzel, vice chairman of Humanity Plus, according to Mr. Goertzel's résumé. "I have no desire to talk about Epstein right now," Mr. Goertzel said in an email to The New York Times. "The stuff I'm reading about him

ion of thinkers who dare to envision humanity's next steps." Mr. Epstein's foundation, which is now defunct, also gave $100,000 to pay the salary of Ben Goertzel, vice chairman of Humanity Plus, according to Mr. Goertzel's résumé. "I have no desire to talk about Epstein right now," Mr. Goertzel said in an em

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been

. Epstein's foundation, which is now defunct, also gave $100,000 to pay the salary of Ben Goertzel, vice chairman of Humanity Plus, according to Mr. Goertzel's résumé. "I have no desire to talk about Epstein right now," Mr. Goertzel said in an email to The New York Times. "The stuff I'm reading about him

ion of thinkers who dare to envision humanity's next steps." Mr. Epstein's foundation, which is now defunct, also gave $100,000 to pay the salary of Ben Goertzel, vice chairman of Humanity Plus, according to Mr. Goertzel's résumé. "I have no desire to talk about Epstein right now," Mr. Goertzel said in an em

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been

. Epstein's foundation, which is now defunct, also gave $100,000 to pay the salary of Ben Goertzel, vice chairman of Humanity Plus, according to Mr. Goertzel's résumé. "I have no desire to talk about Epstein right now," Mr. Goertzel said in an email to The New York Times. "The stuff I'm reading about him

ion of thinkers who dare to envision humanity's next steps." Mr. Epstein's foundation, which is now defunct, also gave $100,000 to pay the salary of Ben Goertzel, vice chairman of Humanity Plus, according to Mr. Goertzel's résumé. "I have no desire to talk about Epstein right now," Mr. Goertzel said in an em

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been